Prasterone: A Review in Vulvovaginal Atrophy

Overview of attention for article published in Drugs & Aging, July 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,524 followers.

RT @doctorneyro: During #52weeks of #treatment with #prasterone, changes in concentns of #estrogen and #androgen metabs of #DHEA remained n…

Reply Repost Favourite

RT @doctorneyro: During #52weeks of #treatment with #prasterone, changes in concentns of #estrogen and #androgen metabs of #DHEA remained n…

Reply Repost Favourite

During #52weeks of #treatment with #prasterone, changes in concentns of #estrogen and #androgen metabs of #DHEA remained norm #postmenopausal rngs. Is an effective and generally well-tolerated option for the treatment of #VVA in postmenopausal #women. ht

Reply Repost Favourite